Has the switch to sexual risk behaviour screening impacted deferrals for pre‐ and post‐exposure prophylaxis therapy for human immunodeficiency virus?

Documenti analoghi

• Removal of deferrals for variant Creutzfeldt–Jakob disease risk: Impact on new and previously deferred donors
  di: Mindy Goldman, et al.
  Pubblicazione: (2025)
• Chagas disease in Canadian blood donors: 15 years of selective testing
  di: Sheila F. O'Brien, et al.
  Pubblicazione: (2026)
• End of selection criteria based on sexual orientation: An international symposium on alternatives to donation deferral
  di: Antoine Lewin, et al.
  Pubblicazione: (2024)
• Notification of blood donors who test positive for transfusion‐transmissible infections
  di: Sheila F. O'Brien, et al.
  Pubblicazione: (2025)
• Comment on ‘Comparing specificity and seroconversion sensitivity among major blood screening assays for human immunodeficiency virus and viral hepatitis’
  di: Ramune Sepetiene, et al.
  Pubblicazione: (2026)